Ceftriaxone and Doxycycline induced Seroconversion in Previously Seronegative Patient with Clinically Suspected Disseminated Lyme Disease: Case Report
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
We present a case of middle-aged woman whose health problems began 3 months after a registered tick bite in endemic area of Lyme borreliosis. First symptoms included fatigue, chills, cervical lymphadenopathy, neck pain and stiffness. Patient was afebrile. Lyme disease was excluded due to lack of erythema migrans and negative enzyme immunoassay test results for anti-Borrelia antibodies. During the next few months, her condition was getting worse and symptoms were accompanied with brain fog, dizziness, palpitations, irregular menstrual cycles, insomnia, panic attacks, headaches, and muscle aches. This led to multiple medical tests and examinations, but the diagnosis failed to be established. Finally, after occurrence of paresthesia and weakness of leg muscles, clinical diagnosis of disseminated Lyme borreliosis with nervous system involvement was suspected and antibiotic therapy was initiated. After the second dose of ceftriaxone, patient got fever and her condition worsened. However, ceftriaxone therapy was continued for a total of 5 days and was followed by 4 weeks of doxycycline therapy. Upon completion of antibiotic therapy, high specific anti-Borrelia antibodies were detected by Western blot and SeraSpot. Appearance of anti-Borrelia antibodies, in contrast to negative test results performed immediately before the therapy started, indicated seroconversion. 18 months after the therapy, patient was completely without the symptoms. This paper emphasizes importance of clinical evaluation of Lyme disease and shows a unique case of seroconversion in patient with symptoms of disseminated Lyme disease. Seroconversion was likely triggered by release of lipoproteins and other immunogenic molecules from Borrelia once the bacterial die-off began due to antibiotic therapy.
Abstract
We present a case of middle-aged woman whose health problems began 3 months after a registered tick bite in endemic area of Lyme borreliosis. First symptoms included fatigue, chills, cervical lymphadenopathy, neck pain and stiffness. Patient was afebrile. Lyme disease was excluded due to lack of erythema migrans and negative enzyme immunoassay test results for anti-Borrelia antibodies. During the next few months, her condition was getting worse and symptoms were accompanied with brain fog, dizziness, palpitations, irregular menstrual cycles, insomnia, panic attacks, headaches, and muscle aches. This led to multiple medical tests and examinations, but the diagnosis failed to be established. Finally, after occurrence of paresthesia and weakness of leg muscles, clinical diagnosis of disseminated Lyme borreliosis with nervous system involvement was suspected and antibiotic therapy was initiated. After the second dose of ceftriaxone, patient got fever and her condition worsened. However, ceftriaxone therapy was continued for a total of 5 days and was followed by 4 weeks of doxycycline therapy. Upon completion of antibiotic therapy, high specific anti-Borrelia antibodies were detected by Western blot and SeraSpot. Appearance of anti-Borrelia antibodies, in contrast to negative test results performed immediately before the therapy started, indicated seroconversion. 18 months after the therapy, patient was completely without the symptoms. This paper emphasizes importance of clinical evaluation of Lyme disease and shows a unique case of seroconversion in patient with symptoms of disseminated Lyme disease. Seroconversion was likely triggered by release of lipoproteins and other immunogenic molecules from Borrelia once the bacterial die-off began due to antibiotic therapy.
참고문헌 (20)
- Wormser GP, "The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America", Clin Infect Dis, 43, pp.1089~1134 (2006)
- Sanchez E, "Diagnosis, Treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: A Review", JAMA, 315, pp.1767~1777
- Steere AC, "Systemic symptoms without erythema migrans as the presenting picture of early Lyme disease", Am J Med, 114, pp.58~62 (2003)
- Leeflang MM, "The diagnostic accuracy of serological tests for Lyme borreliosis in Europe: a systematic review and meta-analysis", BMC Infect Dis, 16, pp.140~ (2016)
- Schutzer SE, "Sequestration of antibody to Borrelia burgdorferi in immune complexes in seronegative Lyme disease", Lancet, 335, pp.312~315 (1990)
- Wagemakers A, "Case report: persistently seronegative neuroborreliosis in an immunocompromised patient", BMC Infect Dis, 18, pp.362~ (2018)
- Dattwyler RJ, "Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi", N Engl J Med, 319, pp.1441~1446 (1988)
- Waddell LA, "The accuracy of diagnostic tests for Lyme disease in humans, a systematic review and meta-analysis of North American research", PLoS One, 11, pp.e0168613~ (2016)
- Butler T, "The Jarisch-Herxheimer reaction after antibiotic treatment of spirochetal infections: a review of recent cases and our understanding of pathogenesis", Am J Trop Med Hyg, 96, pp.46~52 (2017)
- Haney C, "Unique expression of chronic Lyme disease and Jarisch-Herxheimer reaction to doxycycline therapy in a young adult", BMJ Case Rep, 2016 (2016)
- Ogrinc K, "Cerebrospinal fluid findings in patients with symptoms suggesting chronic Lyme borreliosis", Wien Klin Wochenschr, 114, pp.535~538 (2002)
- Ogrinc K, "Suspected early Lyme neuroborreliosis in patients with erythema migrans", Clin Infect Dis, 57, pp.501~509 (2013)
- Rebman AW, "Characteristics of seroconversion and implications for diagnosis of post-treatment Lyme disease syndrome: acute and convalescent serology among a prospective cohort of early Lyme disease patients", Clin Rheumatol, 34, pp.585~589 (2015)
- Johansen P, "Clemastine causes immune suppression through inhibition of extracellular signal-regulated kinase-dependent proinflammatory cytokines", J Allergy Clin Immunol, 128, pp.1286~1294 (2011)
- Rupprecht TA, "The pathogenesis of lyme neuroborreliosis: from infection to inflammation", Mol Med, 14 (2008)
- Negussie Y, "Detection of plasma tumor necrosis factor, interleukins 6, and 8 during the Jarisch-Herxheimer Reaction of relapsing fever", J Exp Med, 175, pp.1207~1212 (1992)
- Galloway RE, "Activation of protein mediators of inflammation and evidence for endotoxemia in Borrelia recurrentis infection", Am J Med, 63, pp.933~938 (1977)
- Cruz AR, "Phagocytosis of Borrelia burgdorferi, the Lyme disease spirochete, potentiates innate immune activation and induces apoptosis in human monocytes.", Infect Immun, 76, pp.56~70 (2008)
- Vijayaraghava A, "Exercise and the cytokines-interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α): A review", Ann Med Physiol, 1, pp.3~8 (2017)
- Carroll MC, "Regulation of humoral immunity by complement", Immunity, 37, pp.199~207 (2012)